KR20170087531A - 게실증의 치료를 위한 방법 및 조성물 - Google Patents
게실증의 치료를 위한 방법 및 조성물 Download PDFInfo
- Publication number
- KR20170087531A KR20170087531A KR1020177020002A KR20177020002A KR20170087531A KR 20170087531 A KR20170087531 A KR 20170087531A KR 1020177020002 A KR1020177020002 A KR 1020177020002A KR 20177020002 A KR20177020002 A KR 20177020002A KR 20170087531 A KR20170087531 A KR 20170087531A
- Authority
- KR
- South Korea
- Prior art keywords
- glutamine
- salt
- diverticulosis
- compositions
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 33
- 206010013554 Diverticulum Diseases 0.000 title claims abstract description 25
- 238000000034 method Methods 0.000 title abstract description 15
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims abstract description 25
- 229930182816 L-glutamine Natural products 0.000 claims abstract description 22
- 150000008540 L-glutamines Chemical class 0.000 claims abstract description 12
- 230000037396 body weight Effects 0.000 claims abstract description 11
- 206010013530 Diverticula Diseases 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 abstract description 16
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 8
- 230000037406 food intake Effects 0.000 abstract description 3
- 239000000835 fiber Substances 0.000 description 16
- -1 citrate salt Chemical class 0.000 description 7
- 238000002052 colonoscopy Methods 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 239000013589 supplement Substances 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 4
- 210000001072 colon Anatomy 0.000 description 4
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical class NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 229940125782 compound 2 Drugs 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000007784 diverticulitis Diseases 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000004381 Choline salt Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 208000012258 Diverticular disease Diseases 0.000 description 1
- 241000792859 Enema Species 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical class CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- 241001499733 Plantago asiatica Species 0.000 description 1
- 235000003421 Plantago ovata Nutrition 0.000 description 1
- 239000009223 Psyllium Substances 0.000 description 1
- 159000000021 acetate salts Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 229940124575 antispasmodic agent Drugs 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 229940029830 benefiber Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007910 chewable tablet Substances 0.000 description 1
- 229960002023 chloroprocaine Drugs 0.000 description 1
- VDANGULDQQJODZ-UHFFFAOYSA-N chloroprocaine Chemical class CCN(CC)CCOC(=O)C1=CC=C(N)C=C1Cl VDANGULDQQJODZ-UHFFFAOYSA-N 0.000 description 1
- 229940081970 citrucel Drugs 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- YKGMKSIHIVVYKY-UHFFFAOYSA-N dabrafenib mesylate Chemical compound CS(O)(=O)=O.S1C(C(C)(C)C)=NC(C=2C(=C(NS(=O)(=O)C=3C(=CC=CC=3F)F)C=CC=2)F)=C1C1=CC=NC(N)=N1 YKGMKSIHIVVYKY-UHFFFAOYSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000007920 enema Substances 0.000 description 1
- 229940095399 enema Drugs 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical class OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 229960003194 meglumine Drugs 0.000 description 1
- 229940042003 metamucil Drugs 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 150000003891 oxalate salts Chemical class 0.000 description 1
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 1
- 235000019371 penicillin G benzathine Nutrition 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 229940070687 psyllium Drugs 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- YBRBMKDOPFTVDT-UHFFFAOYSA-N tert-butylamine Chemical class CC(C)(C)N YBRBMKDOPFTVDT-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 229960000281 trometamol Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229940075430 wheat dextrin Drugs 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/24—Cellulose or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/721—Dextrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161630831P | 2011-12-19 | 2011-12-19 | |
| US61/630,831 | 2011-12-19 | ||
| PCT/US2012/000576 WO2013095681A1 (en) | 2011-12-19 | 2012-12-14 | Methods and compositions for the treatment of diverticulosis |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020147016785A Division KR20140103281A (ko) | 2011-12-19 | 2012-12-14 | 게실증의 치료를 위한 방법 및 조성물 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20170087531A true KR20170087531A (ko) | 2017-07-28 |
Family
ID=48669319
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020177020002A Ceased KR20170087531A (ko) | 2011-12-19 | 2012-12-14 | 게실증의 치료를 위한 방법 및 조성물 |
| KR1020177008405A Active KR101848722B1 (ko) | 2011-12-19 | 2012-12-14 | 게실증의 치료를 위한 방법 및 조성물 |
| KR1020187009799A Ceased KR20180039187A (ko) | 2011-12-19 | 2012-12-14 | 게실증의 치료를 위한 방법 및 조성물 |
| KR1020147016785A Ceased KR20140103281A (ko) | 2011-12-19 | 2012-12-14 | 게실증의 치료를 위한 방법 및 조성물 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020177008405A Active KR101848722B1 (ko) | 2011-12-19 | 2012-12-14 | 게실증의 치료를 위한 방법 및 조성물 |
| KR1020187009799A Ceased KR20180039187A (ko) | 2011-12-19 | 2012-12-14 | 게실증의 치료를 위한 방법 및 조성물 |
| KR1020147016785A Ceased KR20140103281A (ko) | 2011-12-19 | 2012-12-14 | 게실증의 치료를 위한 방법 및 조성물 |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US9616041B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3603631B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6060176B2 (cg-RX-API-DMAC7.html) |
| KR (4) | KR20170087531A (cg-RX-API-DMAC7.html) |
| CN (1) | CN104114165B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2012355956B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112014014765A8 (cg-RX-API-DMAC7.html) |
| DK (1) | DK2793875T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2770585T3 (cg-RX-API-DMAC7.html) |
| IN (1) | IN2014KN01255A (cg-RX-API-DMAC7.html) |
| MX (1) | MX351688B (cg-RX-API-DMAC7.html) |
| RU (2) | RU2733396C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013095681A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2793875T3 (da) * | 2011-12-19 | 2020-02-24 | Emmaus Medical Inc | Fremgangsmåder og sammensætninger til behandlingen af diverticulosis |
| CU20200106A7 (es) | 2018-06-20 | 2021-08-06 | Axcella Health Inc | Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias |
| EP3790545A4 (en) * | 2019-07-17 | 2021-07-28 | Emmaus Medical, Inc. | METHODS AND COMPOSITIONS FOR TREATMENT OF SICKLE CLEANEMIA AND THALASSEMIA |
| US20230053227A1 (en) * | 2021-07-27 | 2023-02-16 | G&S Laboratories, Inc. | Dietary fiber compositions |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1362587A1 (en) * | 1994-01-11 | 2003-11-19 | Stichting Zofia | Use of glutamine for treating low arginine levels in the animal or human body |
| JP2000060487A (ja) * | 1998-08-27 | 2000-02-29 | Kao Corp | 便秘改善剤 |
| US7030092B1 (en) * | 2001-08-24 | 2006-04-18 | Small Giant L.L.C. | Ultra-high fiber supplement and method of reducing weight cardiovascular risks and ingested toxins. |
| US20040005304A1 (en) * | 2002-07-08 | 2004-01-08 | Mak Wood, Inc. | Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions |
| US7988989B2 (en) * | 2003-05-09 | 2011-08-02 | Freedom Health, Llc | Nutritional product for enhancing growth and/or strengthening the immune system of equine foals |
| US20050058671A1 (en) | 2003-05-09 | 2005-03-17 | Bedding Peter M.J. | Dietary supplement and method for treating digestive system-related disorders |
| US8512789B2 (en) * | 2005-11-23 | 2013-08-20 | The Coca-Cola Company | High-potency sweetener composition with dietary fiber and compositions sweetened therewith |
| US20080003265A1 (en) * | 2006-06-28 | 2008-01-03 | John Francis Casey | Protein and fiber containing dietary supplement |
| PL2086346T3 (pl) * | 2006-11-07 | 2013-06-28 | Procter & Gamble | Kompozycje zawierające błonnik oraz sposoby ich wytwarzania i zastosowanie |
| RU2454730C1 (ru) * | 2011-03-15 | 2012-06-27 | Александр Михайлович Пузиков | Способ лечения дивертикулеза в эксперименте |
| DK2793875T3 (da) * | 2011-12-19 | 2020-02-24 | Emmaus Medical Inc | Fremgangsmåder og sammensætninger til behandlingen af diverticulosis |
-
2012
- 2012-12-14 DK DK12860587.0T patent/DK2793875T3/da active
- 2012-12-14 KR KR1020177020002A patent/KR20170087531A/ko not_active Ceased
- 2012-12-14 EP EP19199336.9A patent/EP3603631B1/en active Active
- 2012-12-14 AU AU2012355956A patent/AU2012355956B2/en active Active
- 2012-12-14 WO PCT/US2012/000576 patent/WO2013095681A1/en not_active Ceased
- 2012-12-14 MX MX2014007382A patent/MX351688B/es active IP Right Grant
- 2012-12-14 KR KR1020177008405A patent/KR101848722B1/ko active Active
- 2012-12-14 US US13/694,592 patent/US9616041B2/en active Active
- 2012-12-14 JP JP2014547181A patent/JP6060176B2/ja active Active
- 2012-12-14 RU RU2018126834A patent/RU2733396C2/ru active
- 2012-12-14 KR KR1020187009799A patent/KR20180039187A/ko not_active Ceased
- 2012-12-14 CN CN201280062802.4A patent/CN104114165B/zh active Active
- 2012-12-14 BR BR112014014765A patent/BR112014014765A8/pt not_active Application Discontinuation
- 2012-12-14 RU RU2014123433A patent/RU2662917C2/ru active
- 2012-12-14 EP EP12860587.0A patent/EP2793875B1/en active Active
- 2012-12-14 KR KR1020147016785A patent/KR20140103281A/ko not_active Ceased
- 2012-12-14 ES ES12860587T patent/ES2770585T3/es active Active
-
2014
- 2014-06-10 IN IN1255/KOLNP/2014A patent/IN2014KN01255A/en unknown
-
2017
- 2017-02-10 US US15/530,630 patent/US10258586B2/en active Active
-
2019
- 2019-02-11 US US16/501,039 patent/US11304918B2/en active Active
-
2022
- 2022-03-09 US US17/803,158 patent/US20220202758A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220202758A1 (en) | Methods and compositions for the treatment of diverticulosis | |
| RU2013127423A (ru) | Повышение биодоступности лекарственных средств при терапии налтрексоном | |
| JP5416327B2 (ja) | タキサンにより惹起される神経毒性を予防又は軽減するための薬剤 | |
| JP2016507500A5 (cg-RX-API-DMAC7.html) | ||
| TWI341728B (en) | Combinations comprising epothilones and anti-metabolites | |
| WO2010092436A1 (en) | Pharmaceutical combinations of simethicone and otilonium | |
| US20110117070A1 (en) | Compositions and methods for treating headache | |
| TW201803558A (zh) | 腸內環境改善劑 | |
| CN100594933C (zh) | 抗肥胖剂和健康食品 | |
| JP2024508514A (ja) | 選択的ｃｂ２受容体アゴニストによる処置の方法 | |
| JP2016514142A (ja) | 薬物及び栄養補助剤のバイオアベイラビリティを高める方法及び生成物 | |
| JP6281919B2 (ja) | 高脂肪食への嗜好性を軽減させるための医薬組成物、飲食品組成物または飲食品添加剤 | |
| JP6143215B2 (ja) | 高脂肪食への嗜好性を軽減させるための医薬組成物、飲食品組成物または飲食品添加剤 | |
| JP2017066142A (ja) | 止瀉剤組成物 | |
| CN105377259A (zh) | 提高药物和膳食补充剂的细胞吸收的方法和产品 | |
| JP5822420B2 (ja) | 医薬組成物 | |
| CN111714509A (zh) | 一种薯蓣皂甙在防治运动病的药物中的应用 | |
| CN102655862A (zh) | 用于降低血液中的尿酸值的组合物 | |
| CN105663893A (zh) | 菌黄保肠合剂 | |
| WO2011000563A4 (en) | Eltoprazine for the treatment of weight disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A107 | Divisional application of patent | ||
| A201 | Request for examination | ||
| PA0104 | Divisional application for international application |
Comment text: Divisional Application for International Patent Patent event code: PA01041R01D Patent event date: 20170718 Application number text: 1020147016785 Filing date: 20140619 |
|
| PA0201 | Request for examination | ||
| PG1501 | Laying open of application | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20170919 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20180425 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20170919 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |